These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11742710)

  • 21. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaemia, diabetes and chronic kidney disease: where are we now?
    Stevens PE
    J Ren Care; 2012 Feb; 38 Suppl 1():67-77. PubMed ID: 22348366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.
    Ossa DF; Briggs A; McIntosh E; Cowell W; Littlewood T; Sculpher M
    Pharmacoeconomics; 2007; 25(3):223-37. PubMed ID: 17335308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia.
    Ray-Coquard I; Laplaige P; Vey N; Asselain B; Urbieta M
    Curr Med Res Opin; 2010 Nov; 26(11):2653-60. PubMed ID: 20932223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
    BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Dempke W
    Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
    Abels RI
    Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced erythropoietin levels as a cause of anaemia in patients with lung cancer.
    Cox R; Musial T; Gyde OH
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):511-4. PubMed ID: 3732355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
    Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy.
    Van Wyck DB
    Nephrol Dial Transplant; 2000; 15 Suppl 3():36-9. PubMed ID: 11032356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.
    Markham A; Bryson HM
    Drugs; 1995 Feb; 49(2):232-54. PubMed ID: 7729331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.
    Mel JR; Salar A; Rodríguez CA; Alegre A; González A; Cassinello J; Montesinos J; Gasquet JA; Sánchez J; Saigí E;
    Curr Med Res Opin; 2008 Oct; 24(10):2931-42. PubMed ID: 18775103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
    Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
    Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile.
    Sundal E; Businger J; Kappeler A
    Nephrol Dial Transplant; 1991; 6(12):955-65. PubMed ID: 1798595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing cancer-related anaemia with epoetin alfa.
    Itri LM
    Nephrol Dial Transplant; 2002; 17 Suppl 1():73-7. PubMed ID: 11812917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS).
    Gascón P; Almenárez J; Artal Á; Camps C; Fírvida JL; Garrido P; González Larriba JL; Montalar J
    Clin Transl Oncol; 2011 May; 13(5):328-34. PubMed ID: 21596661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of C.E.R.A. in Routine Clinical Practice for Correction of Anaemia and Maintenance of the Haemoglobin Levels in CKD Patients not on Dialysis.
    Promod PJ; Deshpande R; Mohanty NK; Kulkarni S; Shah HA; Ganju A; Kukreja A; Joshi S
    J Assoc Physicians India; 2017 Mar; 65(3):52-57. PubMed ID: 28462544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.
    Chen L; Jiang H; Gao W; Tu Y; Zhou Y; Li X; Zhu Z; Jiang Q; Zhan H; Yu J; Fu C; Gao Y
    BMJ Open; 2016 Oct; 6(10):e012231. PubMed ID: 27855097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.